BioWorld

March 1, 2006

View Archived Issues

ImQuest Gains Dual-Mechanism HIV Compounds From Samjin

Though it’s only a month into a strategic drug development agreement between ImQuest Pharmaceuticals Inc. and Samjin Pharmaceutical Co. Ltd., the alliance already has yielded its first licensing deal. (BioWorld Today) Read More

Advanced Life Sciences Bringing In $36M Growth

Read More

Memory, Roche Amend Deal On Nicotinic Alpha-7 Agonists

Read More

Other News To Note

Read More